Timing of Pediatric Palliative Care Consults in Hospitalized Patients with Heart Disease

Danielle J Green1, Erin Bennett2, Lenora M Olson1

  • 1Department of Pediatrics, Division of Pediatric Critical Care, University of Utah, Salt Lake City, Utah, United States.

Insights

Pediatric palliative care (PPC) referral for children with complex heart disease is often delayed. Early PPC consultation at diagnosis can improve support and care for these patients and their families.

Area of Science:

  • Pediatric Cardiology
  • Palliative Care
  • Complex Chronic Conditions

Background:

  • Children with complex heart disease face lifelong morbidities, frequent hospitalizations, and early mortality risks.
  • Pediatric palliative care (PPC) offers crucial support for symptom management, decision-making, and advanced care planning.
  • Current PPC referral patterns often occur late in the disease trajectory, limiting potential benefits.

Purpose of the Study:

  • To analyze the timing of pediatric palliative care consultations in relation to diagnosis, complex chronic conditions (CCCs), and death in hospitalized pediatric heart disease patients.
  • To evaluate the impact of delayed PPC referral on patient outcomes and care.

Main Methods:

  • Retrospective analysis of 113 hospitalized pediatric patients with a primary diagnosis of heart disease and a PPC consult.
  • Data collected on age at diagnosis, age at PPC consultation, number of CCCs, and time to death.
  • Analysis of the location and mode of death.

Main Results:

  • Median age at heart disease diagnosis was 0 days, with a median of two CCCs.
  • Median age at PPC consultation was 77 days, with a median of four CCCs, indicating a significant delay.
  • Median time from PPC consult to death was 33 days; death frequently occurred in the ICU (67%) via withdrawal of life-sustaining therapies (57%).

Conclusions:

  • PPC referral often occurs late, amidst medical complexity and prolonged hospitalizations.
  • Early PPC consultation at the time of heart disease diagnosis is recommended to maximize benefits beyond end-of-life care.
  • Timely PPC integration, especially for neonates and infants with CCCs, may influence the mode and location of death and enhance family support.

Related Concept Videos

Continuing Care01:25

Continuing Care

Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.5K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
21
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
22
Pulse rhythm01:30

Pulse rhythm

Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
878
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
22
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
15